Medication info
Promethin Tablet (Memantine Hydrochloride)

Promethin Tablet (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201800311 · Approved 2018.01.23 · Insurance code 647204940

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg each week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg once daily for 7 days. Week 3 (Days 15–21): Administer 15mg once daily for 7 days. From Week 4 onward: Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose titration schedule. In patients with severe renal impairment (creatinine clearance 5-29mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg each week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg once daily for 7 days. Week 3 (Days 15–21): Administer 15mg once daily for 7 days. From Week 4 onward: Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose titration schedule. In patients with severe renal impairment (creatinine clearance 5-29mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be administered to certain patients. Firstly, it should not be used in patients with an allergy to its components, those with severe liver dysfunction, and patients with greatly reduced kidney function. In addition, it contains lactose, thus it should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. Secondly, caution is required when administering to some patients. Patients with epilepsy or those who have experienced seizures in the past, as well as patients at risk for seizures, need to be monitored carefully. Furthermore, when used in combination with other medications that have similar effects, the risk of side effects may increase, therefore co-administration should be avoided. Patients expected to have changes in urine acidity, recent myocardial infarction or heart failure, and uncontrolled hypertension should also be monitored closely. While taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, so it is important to monitor the patient's condition. Additionally, this medication may interact with other drugs, so if the patient is taking other medications, it is essential to consult with a physician or pharmacist. Particularly, caution is necessary when co-administering anticoagulants, certain gastrointestinal medications, and psychiatric medications. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of this medication, and breastfeeding mothers are advised to stop breastfeeding while on this medication. It is advisable not to use this medication for children or adolescents under 18 years of age as safety and efficacy have not been established. In cases of overdose, symptoms such as confusion, drowsiness, hallucinations, and seizures may occur, and in such a case, immediate medical attention is required. This medication may decrease the speed of response and attention, thus caution is necessary when driving or operating machinery. Lastly, this medication must be stored out of reach of children, and it is safer to keep it in its original packaging without changing containers.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucination
  • psychotic reaction
Show 24 more
  • balance disorder
  • gait disturbance
  • seizure
  • heart failure
  • venous thrombosis/thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function test values
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • lethargy
  • diarrhea
  • anxiety
  • aggressiveness
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • coma
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the integrity of the medication's components and effectiveness.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.